Movember Discovery Grants

Access to the Online Application: https://pccgrants.smartsimple.ca
Registration Deadline: February 15, 2017
Full Application Deadline: April 3, 2017
Funding Start Date: July 1, 2017smaller.jpg



Prostate Cancer Canada (PCC) is offering a limited number of Discovery Grants. While supporting novel research that aims to open up new lines of investigation, the goal is to support new and innovative studies in prostate cancer research.
The Discovery Grant program will:
  • allow both junior and more established investigators to pursue new avenues of exploration
  • allow applications from all areas of prostate cancer research
  • provide a budget of up to $200,000 per project that can be spent in up to two years of funding, thereby allowing some flexibility
  • fund applications that will have been evaluated by a rigorous peer-review process that assessed:
    • Innovation
    • Track record of investigator team
    • Feasibility of the proposed work
    • Potential impact on prostate cancer

The proposed research project must be in the area of prostate cancer and may address any of the broad areas of prostate cancer research, including but not limited to:
  • biomedical
  • clinical
  • population health
  • health services/economics

This opportunity is proudly funded by the Movember Foundation.


Discovery Grants that are based at institutions in New Brunswick and have met both scientific meritorious and financial cut-off requirements will be co-funded by PCC and the New Brunswick Health Research Foundation.

Links to:
Online application: https://pccgrants.smartsimple.ca
Program Description
Tipsheet for applicants


 




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Rocco Rossi to wrap up successful 5-year tenure as Prostate Cancer Canada CEO

September 7, 2017 - TORONTO, ON - With mixed emotions, longstanding Prostate Cancer Canada (PCC) President and CEO, Rocco Rossi, formally announced today that his time leading the organization will officially come to a close as of December 31, 2017.
More

Mutation in prostate tumours shown to change epigenetic identity, the make-up of DNA

(TORONTO, Canada - Aug 7, 2017) -- Prostate cancer researchers have mapped the impact of an acquired mutation that alters epigenetic identity, the make-up of DNA, in about 50% of patient tumour samples.
More

Movember Foundation and Prostate Cancer Canada team up to turn research into results

July 26, 2017 - TORONTO, ON - Continuing their longstanding tradition of partnering to fund high quality Canadian prostate cancer research, Prostate Cancer Canada (PCC) and The Movember Foundation today announced two new projects with very real potential to make a tangible difference in the lives of men living with aggressive forms of prostate cancer.
More


Click here for news archive